Combined Oral Contraceptive

Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills

Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis

Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome

Impact of Combined Oral Contraceptive Pills on Migraine

HSG and Tubal Patency Study

A single center, randomized, open-label, controlled, three-arm study to evaluate the effect of a new combined oral contraceptive (COC) containing 15 mg Estetrol (E4) and 3 mg Drospirenone (DRSP) and of two reference COCs containing either 30 mcg Ethinylestradiol (EE) and 150 mcg Levonorgestrel (LNG) or 20 mcg EE and 3 mg DRSP on endocrine function, metabolic control and hemostasis during 6 treatment cycles

Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases